Drug application
VERSAPEN-K (HETACILLIN POTASSIUM)
Drugs@FDA ANDA 061396 · BRISTOL
Key facts
| Drug name | VERSAPEN-K |
|---|---|
| Active ingredients | HETACILLIN POTASSIUM |
| Application type | ANDA |
| Application number | 061396 |
| Company | BRISTOL |
| Dosage forms | CAPSULE, ORAL |
| Strength | EQ 225MG AMPICIL |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | Mar 3, 1971 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.